Synthetic cannabis-like drug reduces sleep apnea
(Northwestern University) A synthetic cannabis-like drug in a pill reduced apnea and daytime sleepiness in the first large multi-site study of a drug for apnea. The drug targets the brain in a new treatment strategy. There is currently no drug treatment for sleep apnea, a sleep breathing disorder affecting about 30 million individuals in the US. Untreated apnea raises the risk of heart disease, diabetes, sleepiness, cognitive impairment and a motor vehicle accident.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Accidents | Brain | Cardiology | Diabetes | Endocrinology | Heart | Heart Disease | International Medicine & Public Health | Neurology | Sleep Apnea | Sleep Disorders | Sleep Medicine | Study